loadpatents
name:-0.039447069168091
name:-0.026236057281494
name:-0.03167986869812
Vaka; Siva Ram Kiran Patent Filings

Vaka; Siva Ram Kiran

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vaka; Siva Ram Kiran.The latest application filed is for "extended release compositions comprising trihexyphenidyl".

Company Profile
32.25.34
  • Vaka; Siva Ram Kiran - Piscataway NJ
  • Vaka; Siva Ram Kiran- - Piscataway NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Programmable pharmaceutical compositions for chrono drug release
Grant 11,439,585 - Vaka , et al. September 13, 2
2022-09-13
Programmable pharmaceutical compositions for chrono drug release
Grant 11,419,813 - Vaka , et al. August 23, 2
2022-08-23
Extended Release Compositions Comprising Trihexyphenidyl
App 20220249377 - Shelke; Namdev B. ;   et al.
2022-08-11
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20220218604 - Meghpara; Kanji ;   et al.
2022-07-14
Delayed Release Methylphenidate Compositions
App 20220133635 - Vaka; Siva Ram Kiran ;   et al.
2022-05-05
Gastroretentive dosage forms for sustained drug delivery
Grant 11,318,091 - Meghpara , et al. May 3, 2
2022-05-03
Extended Release Compositions Comprising Pyridostigmine
App 20220096386 - Vaka; Siva Ram Kiran ;   et al.
2022-03-31
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20220096366 - Vaka; Siva Ram Kiran ;   et al.
2022-03-31
Delayed Release Compositions
App 20220079896 - Meghpara; Kanji ;   et al.
2022-03-17
Delayed Release Methylphenidate Compositions
App 20220040114 - Vaka; Siva Ram Kiran ;   et al.
2022-02-10
Extended release compositions comprising pyridostigmine
Grant 11,229,606 - Vaka , et al. January 25, 2
2022-01-25
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210393512 - Vaka; Siva Ram Kiran ;   et al.
2021-12-23
Programmable pharmaceutical compositions for chrono drug release
Grant 11,166,906 - Vaka , et al. November 9, 2
2021-11-09
Extended Release Compositions Comprising Trihexyphenidyl
App 20210330657 - Shelke; Namdev B. ;   et al.
2021-10-28
Programmable pharmaceutical compositions for chrono drug release
Grant 11,154,494 - Vaka , et al. October 26, 2
2021-10-26
Extended release compositions comprising trihexyphenidyl
Grant 11,154,505 - Shelke , et al. October 26, 2
2021-10-26
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210236421 - Meghpara; Kanji ;   et al.
2021-08-05
Extended Release Compositions Comprising Pyridostigmine
App 20210236429 - Shelke; Namdev B. ;   et al.
2021-08-05
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210228474 - Vaka; Siva Ram Kiran ;   et al.
2021-07-29
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210205207 - Vaka; Siva Ram Kiran ;   et al.
2021-07-08
Extended release compositions comprising trihexyphenidyl
Grant 11,045,420 - Shelke , et al. June 29, 2
2021-06-29
Extended release compositions comprising trihexyphenidyl
Grant 11,040,014 - Shelke , et al. June 22, 2
2021-06-22
Gastroretentive dosage forms for sustained drug delivery
Grant 11,007,145 - Meghpara , et al. May 18, 2
2021-05-18
Programmable pharmaceutical compositions for chrono drug release
Grant 11,000,471 - Vaka , et al. May 11, 2
2021-05-11
Extended release compositions comprising pyridostigmine
Grant 10,987,311 - Vaka , et al. April 27, 2
2021-04-27
Programmable pharmaceutical compositions for chrono drug release
Grant 10,980,738 - Vaka , et al. April 20, 2
2021-04-20
Opioid agonist / antagonist combination dosage forms
Grant 10,960,001 - Shah , et al. March 30, 2
2021-03-30
Extended Release Compositions Comprising Pyridostigmine
App 20210069117 - Vaka; Siva Ram Kiran ;   et al.
2021-03-11
Extended release compositions comprising pyridostigmine
Grant 10,925,833 - Shelke , et al. February 23, 2
2021-02-23
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038523 - Shelke; Namdev B. ;   et al.
2021-02-11
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038524 - Shelke; Namdev B. ;   et al.
2021-02-11
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210030685 - Vaka; Siva Ram Kiran ;   et al.
2021-02-04
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210022999 - Meghpara; Kanji ;   et al.
2021-01-28
Programmable pharmaceutical compositions for chrono drug release
Grant 10,898,431 - Vaka , et al. January 26, 2
2021-01-26
Extended release compositions comprising pyridostigmine
Grant 10,881,617 - Vaka , et al. January 5, 2
2021-01-05
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200405626 - Vaka; Siva Ram Kiran ;   et al.
2020-12-31
Extended release compositions comprising trihexyphenidyl
Grant 10,869,839 - Shelke , et al. December 22, 2
2020-12-22
Extended Release Compositions Comprising Pyridostigmine
App 20200383923 - Shelke; Namdev B. ;   et al.
2020-12-10
Gastroretentive dosage forms for sustained drug delivery
Grant 10,857,098 - Meghpara , et al. December 8, 2
2020-12-08
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200261359 - Meghpara; Kanji ;   et al.
2020-08-20
Extended Release Compositions Comprising Trihexyphenidyl
App 20200261372 - Shelke; Namdev B. ;   et al.
2020-08-20
Extended release compositions comprising pyridostigmine
Grant 10,744,093 - Vaka , et al. A
2020-08-18
Abuse-resistant drug formulations
Grant 10,744,131 - Sandhu , et al. A
2020-08-18
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200253861 - Kind Code
2020-08-13
Extended Release Compositions Comprising Pyridostigmine
App 20200163889 - Vaka; Siva Ram Kiran ;   et al.
2020-05-28
Abuse-resistant drug formulations with built-in overdose protection
Grant 10,632,113 - Vaka , et al.
2020-04-28
Extended release compositions comprising pyridostigmine
Grant 10,588,863 - Vaka , et al.
2020-03-17
Extended Release Compositions Comprising Pyridostigmine
App 20190388351 - Vaka; Siva Ram Kiran ;   et al.
2019-12-26
Extended Release Compositions Comprising Pyridostigmine
App 20190374473 - Vaka; Siva Ram Kiran ;   et al.
2019-12-12
Opioid Agonist / Antagonist Combination Dosage Forms
App 20190358221 - Shah; Navnit H. ;   et al.
2019-11-28
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20190343957 - Vaka; Siva Ram Kiran ;   et al.
2019-11-14
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
Grant 10,406,234 - Vaka , et al. Sept
2019-09-10
Overdose Protection And Abuse Deterrent Immediate Release Drug Formulation
App 20190054031 - Shah; Navnit H. ;   et al.
2019-02-21
Food Independent Immediate Release Drug Formulation With Abuse Deterrence And Overdose Protection
App 20180296486 - Shah; Navnit H. ;   et al.
2018-10-18
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20170173157 - VAKA; Siva Ram Kiran ;   et al.
2017-06-22
Self-nanoemulsion of poorly soluble drugs
Grant 9,511,078 - Desai , et al. December 6, 2
2016-12-06
Abuse-resistant Drug Formulations With Built-in Overdose Protection
App 20160346274 - Vaka; Siva Ram Kiran ;   et al.
2016-12-01
Abuse-resistant Drug Formulations
App 20160317530 - Sandhu; Harpreet Kaur ;   et al.
2016-11-03
Self-nanoemulsion Of Poorly Soluble Drugs
App 20160151392 - Desai; Dipen ;   et al.
2016-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed